» Articles » PMID: 2403437

Prospects for Antiestrogen Chemoprevention of Breast Cancer

Overview
Specialty Oncology
Date 1990 Jan 3
PMID 2403437
Citations 4
Authors
Affiliations
Soon will be listed here.
Citing Articles

Complementary or alternative medicine as possible determinant of decreased persistence to aromatase inhibitor therapy among older women with non-metastatic breast cancer.

Huiart L, Bouhnik A, Rey D, Rousseau F, Retornaz F, Meresse M PLoS One. 2013; 8(12):e81677.

PMID: 24367488 PMC: 3867346. DOI: 10.1371/journal.pone.0081677.


Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer.

Huiart L, DellAniello S, Suissa S Br J Cancer. 2011; 104(10):1558-63.

PMID: 21522148 PMC: 3101914. DOI: 10.1038/bjc.2011.140.


Clinical management of women at increased risk for breast cancer.

Vogel V, YEOMANS A, Higginbotham E Breast Cancer Res Treat. 1993; 28(2):195-210.

PMID: 8173071 DOI: 10.1007/BF00666431.


Prevention of breast cancer recurrence with adjuvant cytotoxic or endocrine therapy.

Rutqvist L Med Oncol Tumor Pharmacother. 1991; 8(3):163-8.

PMID: 1803176 DOI: 10.1007/BF02987175.